174 related articles for article (PubMed ID: 3630545)
1. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
Botella J; Paris J; Lahlou B
Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
[TBL] [Abstract][Full Text] [Related]
2. Antiandrogenic properties of nomegestrol acetate.
Duc I; Botella J; Bonnet P; Fraboul F; Delansorne R; Paris J
Arzneimittelforschung; 1995 Jan; 45(1):70-4. PubMed ID: 7893274
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
[TBL] [Abstract][Full Text] [Related]
4. An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.
Shields-Botella J; Duc I; Duranti E; Puccio F; Bonnet P; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):111-22. PubMed ID: 14672731
[TBL] [Abstract][Full Text] [Related]
5. Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.
Labrie C; Simard J; Zhao HF; Pelletier G; Labrie F
Mol Cell Endocrinol; 1990 Jan; 68(2-3):169-79. PubMed ID: 2138099
[TBL] [Abstract][Full Text] [Related]
6. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
[TBL] [Abstract][Full Text] [Related]
7. The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.
Bullock LP; Barthe PL; Mowszowicz I; Orth DN; Bardin CW
Endocrinology; 1975 Jul; 97(1):189-95. PubMed ID: 1140168
[TBL] [Abstract][Full Text] [Related]
8. [Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate].
André G
J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):69-84. PubMed ID: 15767920
[TBL] [Abstract][Full Text] [Related]
9. Interaction of [3H]nomegestrol acetate with cytosolic progesterone receptors from the rat uterus.
Duc I; Botella J; Delansorne R; Paris J
Steroids; 1991 Jun; 56(6):325-8. PubMed ID: 1926229
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate.
Poyet P; Labrie F
Mol Cell Endocrinol; 1985 Oct; 42(3):283-8. PubMed ID: 3930312
[TBL] [Abstract][Full Text] [Related]
11. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
Steinsapir J; Mora G; Muldoon TG
Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
[TBL] [Abstract][Full Text] [Related]
12. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.
Saartok T; Dahlberg E; Gustafsson JA
Endocrinology; 1984 Jun; 114(6):2100-6. PubMed ID: 6539197
[TBL] [Abstract][Full Text] [Related]
13. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
[TBL] [Abstract][Full Text] [Related]
14. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
Huang JK; Bartsch W; Voigt KD
Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Plante M; Lapointe S; Labrie F
J Steroid Biochem; 1988 Jul; 31(1):61-4. PubMed ID: 2456423
[TBL] [Abstract][Full Text] [Related]
16. Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate.
Simoncini T; Caruso A; Garibaldi S; Fu XD; Giretti MS; Baldacci C; Scorticati C; Fornari L; Mannella P; Genazzani AR
Obstet Gynecol; 2006 Oct; 108(4):969-78. PubMed ID: 17012461
[TBL] [Abstract][Full Text] [Related]
17. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Africander DJ; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
[TBL] [Abstract][Full Text] [Related]
19. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
[TBL] [Abstract][Full Text] [Related]
20. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
